Is eating more red meat bad for your brain?

Processed red meat linked to increased risk of dementia

17-Jan-2025 - People who eat more red meat, especially processed red meat like bacon, sausage and bologna, are more likely to have a higher risk of cognitive decline and dementia when compared to those who eat very little red meat, according to a study published in the January 15, 2025, online issue of ...

Merck Reiterates Confidence in Returning to Sustainable Growth

Tailwind thanks to robust global growth trends in all three business sectors

18-Oct-2024 - Merck is looking confidently toward the future. At the Capital Markets Day, the company shared its expectation of profitable and financially strong growth in the coming years. After the transitional year of 2023, Merck considers the medium-term growth opportunities in its markets to be intact. ...

Long COVID makes thinking slower

Objective evidence for mental fatigue

31-Oct-2023 - Characteristic of the attention and concentration problems in Long COVID is slowed information processing. With this result, neuropsychological studies of the University Hospital Jena can objectively prove the cognitive impairment often reported by affected persons. This also provides a target ...

Is the Genie Out of the Bottle? Can you trust ChatGPT in scientific writing?

Differences between veterinary articles difficult to determine

23-Oct-2023 - Since its launch in November 2022, ChatGPT, a state-of-the-art language model developed by OpenAI, L.L.C. in San Francisco, CA, USA, has garnered the attention of the scientific community. As debates about ChatGPT’s impact on every aspect of academia surge worldwide, a team from the University of ...

Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery

Partnerships with BenevolentAI and Exscientia to drive accelerated drug discovery with higher probability of success

20-Sep-2023 - Merck announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery capabilities, further advancing the company’s research efforts. The partnerships, with BenevolentAI, London, U.K., and Exscientia, Oxford, U.K., ...

Getting kids outdoors can reduce the negative effects of screen time

Researchers find that reducing the negative effects of screen time on little minds might be as simple as encouraging kids to play outside

26-Jan-2023 - If you have young children, you’re likely worried about how much time they spend staring at a screen, be it a tablet, phone, computer, or television. You probably also want to know how screen time affects your child’s development and wonder whether there’s anything you can do to balance out any ...

Merck Aims to Double R&D Productivity in Oncology, Neurology and Immunology

Merck shared updates on the company’s healthcare research and development strategy, aimed at doubling R&D productivity

22-Nov-2022 - To achieve the goal of introducing one new product or major indication every 1.5 years on average, the company will focus its expertise and capabilities and leverage synergies within the existing pipeline to deliver transformative medicines in Oncology, Neurology and Immunology, augmented by an ...

Curve Therapeutics Announces Collaboration with MSD for Next Generation Drug Discovery Platform

Potentially game-changing platform enables direct discovery of functionally active molecules

22-Feb-2022 - Curve Therapeutics, a private biotechnology startup pioneering a potentially game-changing,functional drug discovery platform, announces a global research collaboration with MSD, the trade name of Merck & Co., Inc., Kenilworth, NJ USA, to discover and validate modulators of up to five ...

Merck acquires Swiss biotech start-up

Merck Expands Neuroinflammatory Pipeline with Acquisition of Chord Therapeutics

22-Dec-2021 - Merck announced a strategically focused expansion of its neurology pipeline with the acquisition of the rights to develop cladribine for the treatment of generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Merck entered into an agreement to secure the global ...

Merck and B. Braun Join Forces in the Development of Bioelectronic Devices

05-Jul-2021 - Merck announced a collaboration in its new Bioelectronics innovation field with neuroloop GmbH – a B. Braun subsidiary and early-stage start-up company. B. Braun SE is one of the world’s leading manufacturers of medical technology and pharmaceutical products. The collaboration seeks to develop a ...